BAXTER INTERNATIONAL INC 4

4 · BAXTER INTERNATIONAL INC · Filed Jul 6, 2015

Form 4

Period: 2015-07-01

Corporate Vice President

Transactions

Other
Common Stock, par value $1 per share
2015-07-01+13,253→ 95,459 total
Other
Stock Option (Right to Buy)
2015-07-01+99,662→ 215,941 total
Exercise: $37.38Exp: 2025-03-03→ Common Stock, par value $1 per share (99,662 underlying)

Holdings

Stock Option (Right to Buy)
Exercise: $31.30Exp: 2018-03-05→ Common Stock, par value $1 per share (13,000 underlying)
13,000
Stock Option (Right to Buy)
Exercise: $28.97Exp: 2021-03-04→ Common Stock, par value $1 per share (19,851 underlying)
19,851
Stock Option (Right to Buy)
Exercise: $30.95Exp: 2022-03-06→ Common Stock, par value $1 per share (78,753 underlying)
78,753
Stock Option (Right to Buy)
Exercise: $37.82Exp: 2023-03-05→ Common Stock, par value $1 per share (83,267 underlying)
83,267
Stock Option (Right to Buy)
Exercise: $31.77Exp: 2020-03-03→ Common Stock, par value $1 per share (32,410 underlying)
32,410
Stock Option (Right to Buy)
Exercise: $37.17Exp: 2024-03-04→ Common Stock, par value $1 per share (90,284 underlying)
90,284

Footnotes (7)

[F1]In connection with the spin-off (the "Spin-off") of Baxalta Incorporated ("Baxalta") from Baxter International Inc. ("Baxter"), the reporting person received a grant of 13,253 restricted stock units as a result of the adjustment of existing Baxter restricted stock units held by the reporting person prior to the Spin-off. These restricted stock units will vest in three equal annual installments beginning on March 3, 2016, the first anniversary of the grant date.
[F2]Represents options to purchase Baxter common stock awarded to the reporting person prior to the Spin-off. In connection with the Spin-off, the exercise price of the option was adjusted, and the reporting person received options to purchase shares of Baxalta common stock, to preserve the pre-Spin-off intrinsic value of the existing Baxter option award.
[F3]This option is presently exercisable in full.
[F4]Two-thirds of this option is presently exercisable. The remaining one third becomes exercisable on March 5, 2016.
[F5]One-third of this option is presently exercisable. The remaining two thirds become exercisable on March 4, 2016 and March 4, 2017.
[F6]In connection with the Spin-off, the number of shares subject to this option and the exercise price have been adjusted to preserve the pre-Spin-off intrinsic value of the existing Baxter option award.
[F7]This option will vest in three equal annual installments beginning on March 3, 2016, the first anniversary of the grant date of the existing option award.

Documents

1 file